How to Protect Your Lab’s Proprietary LDTs and Assess the Financial Impact of Compliance

McDonald Hopkins' Jane Pine Wood will be presenting as part of a panel on "How to Protect Your Lab’s Proprietary LDTs and Assess the Financial Impact of Compliance" during this webinar presented by the Dark Daily.

You already know that the FDA’s final rule on Laboratory Developed Tests (LDTs) proposes a radical overhaul of the regulatory status quo that governed these tests for decades. What you don’t know yet are specific steps your lab must follow to bring your existing LDTs into compliance with the new rule so you can continue to offer these LDTs to your clients and produce revenue for your lab.

The FDA’s LDT rule is a game-changer for your laboratory. But what you may not realize is how many actions your team must take in the eight short months before the May 6, 2025, compliance deadline arrives. The good news is we can give you a running start to ensure your lab’s most important LDTS are fully compliant by the deadline—thus protecting lab revenue from these LDTs while supporting patient care.